![](https://investorshub.advfn.com/uicon/507416.png?cb=1538015923)
Friday, February 11, 2022 5:36:42 AM
NMIBC NONRESPONSE FIRST IN CLASS
Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine February 7, 2022
The three month chart showS current market expectations.
SESN run from .37 to over 6 DOLLARS US
SESN BACKBURER FROM THE FDA ON THEIR NMIBC STUDY WAS THE BURNER.
jmo
TLTFF The data and science and time appear to be in strong favor of
$TLTFF
TLTFF Long
JMO, maybe, maybe not.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM